Sorry, there was a problem with that video search. Don't worry, we'll fix it shortly!
Search Results
Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myeloma
Bispecifics & CAR-T therapy in DLBCL: sequencing and selecting between these agents
Factors to consider when sequencing therapies in myeloma
Treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
CAR-T, bispecifics and MRD: how is treatment for multiple myeloma evolving?
Sequencing BCMA Myeloma Therapies
The Latest Insights on Immune Therapies in Myeloma | 2023 IMF Patient and Family Seminar
Insights into new BiTE developments in multiple myeloma
Evaluating nivolumab-based therapy to restore T-cell fitness in patients with R/R multiple myeloma
Novel technologies in multiple myeloma and how these are changing the field
Hitting the BCMA Target in Multiple Myeloma
An insight into the changing role of transplantation for myeloma & lymphoma in the era of CAR-T